Symptoms after 2 years of taking ofatumumab

Ofatumumab is a drug used to treat certain types of leukemia and multiple myeloma. This drug works on specific proteins to help control the growth and spread of cancer cells. Symptoms may improve after two years of ofatumumab use, but each person’s condition and treatment response are different, and specific symptoms after two years of use of ofatumumab need to be determined based on individual circumstances.

In the early stage of treatment with ofatumumab, symptoms may not improve significantly, and some discomfort reactions may even occur, such as nausea, vomiting, headache, fatigue, etc. These reactions are usually temporary, and doctors will take appropriate measures based on the specific situation. As treatment continues, ofatumumab may gradually reduce or control the growth of cancer cells, thereby alleviating related symptoms. This may include anemia, bone pain, infection, and more. As treatment continues, ofatumumab may gradually reduce or control the growth of cancer cells, thereby alleviating related symptoms. This may include anemia, bone pain, infection, and more.

The original drug of ofatumumab has been launched in China and has also been included in medical insurance. Only patients who meet the indications can be reimbursed. The price is around tens of thousands of yuan, and domestic purchase channels are relatively difficult. The European version of ofatumumab original drug specifications20mg/0.4mL each sold overseas may cost around RMB 16,000 (the price may fluctuate due to the exchange rate). It is expensive and there are currently no generics of ofatumumab. For more drug information and specific prices, please consult a medical consultant.